share_log

迈威生物自愿披露关于9MW2821联合特瑞普利单抗一线治疗尿路上皮癌纳入突破性治疗品种公示名单的公告

Maiwei Biotech voluntarily disclosed an announcement on the inclusion of 9MW2821 and treprilizumab in the first-line treatment of urothelial cancer in the public list of breakthrough treatment varieties

SZSI ·  Jan 9

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.